Request a copy

Full Text

• Ashcroft F.M. Annu. Rev. Neurosci. 1988, 11:97.
• Grover G.J., McCullouch J.R., Henry D.E., Conder M.L., Sleph P.G. J. Pharmacol. Exp. Ther. 1989, 251:98.
• Murphy K.P.S.J., Greenfield S.A. Exp. Brain Res. 1991, 84:355.
• Escande D., Cavero I. Trends Pharmacol. Sci. 1992, 13:269.
• Noma A. Nature (London) 1983, 305:147.
• Cook D.L., Hales C.N. Nature (London) 1984, 311:271.
• Spruce A.E., Standen N.B., Stanfield P.R. Nature (London) 1985, 316:736.
• Standen N.B., Quayle J.M., Davies N.W., Brayden J.E., Huang Y., Nelson M.T. Science 1989, 245:177.
• Bernardi H., Fosset M., Lazdunski M. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:9816.
• Edwards G., Weston A.H. Trends Pharmacol. Sci. 1990, 11:417.
• Robertson D.W., Steinberg M.I. J. Med. Chem. 1990, 33:1529.
• Longman S.D., Hamilton T.C. Med. Res. Rev. 1992, 12:73.
• Grant T.L., Zuzack J.S. J. Pharmacol. Exp. Ther. 1991, 259:1158.
• Weston A.H., Edwards G. Biochem. Pharmacol. 1992, 43:47.
• Gopalakrishnan M., Johnson D.E., Janis R.A., Triggle D.J. J. Pharmacol. Exp. Ther. 1991, 257:1162.
• Hamilton T.C., Weston A.H. Gen. Pharmacol. 1989, 20:1.
• Newgreen D.T., Bray K.M., McHarg A.D., Weston A.H., Duty S., Brown B.S., Kay P.B., Edwards G., Longmore J., Southerton J.S. Br. J. Pharmacol. 1990, 100:605.
• Garrino M.G., Plant T.D., Henquin J.C. Br. J. Pharmacol. 1989, 98:957.
• Lebrun P., Devreux V., Hermann M., Herchuelz A. J. Pharmacol. Exp. Ther. 1989, 250:1011.
• Lebrun P., Antoine M.‐H., Devreux V., Hermann M., Herchuelz A. J. Pharmacol. Exp. Ther. 1990, 255:948.
• Schwanstecher M., Brandt C., Behrends S., Schaupp U., Panten U. Br. J. Pharmacol. 1992, 106:295.
• Schwanstecher M. Ion Channel Structure and Modulation. New Possibilities for Drug Development, IBC Technical Services Ltd., London; 1992.
• Evans J.M., Stemp G. Potassium Channels '90. Structure, Modulation, and Clinical Exploitation, IBC Technical Services Ltd., London; 1990.
• Topliss J.G., Yudis M.D. J. Med. Chem. 1972, 15:394.
• Wollweber H., Horstmann H., Stoepel K., Garthoff B., Puls W., Krause H.P., Thomas G. Arzneim.‐Forsch./ Drug Res. 1981, 31:279.
• Johnson C.K., ‘ORTEP II’, ‘A Fortran Thermal‐Ellipsoïd Plot Program for Crystal Structure Illustrations’, ORNL‐3794, revised, Oak Ridge, Tennessee, USA; 1972.
• PLUTO, Cambridge Structural Database System, University of Cambridge, U.K.; 1978.
• Rahim Z., Barman B.N. (1978) The van der Waals criterion for hydrogen bonding. Acta Crystallographica Section A 34:761.
• Nyburg S.C., Faerman C.H. (1985) A revision of van der Waals atomic radii for molecular crystals: N, O, F, S, Cl, Se, Br and I bonded to carbon. Acta Crystallographica Section B Structural Science 41:274.
• Durant G.T., Emmett J.C., Ganellin R.C., Miles P.D., Parsons M.E., Prain H.D., White G.R. J. Med. Chem. 1977, 20:901.
• Bach R.D., McDouall J.J.W., Owensby A.L., Schlegel H.B., Holubka J.W., Ball J.C. (1991) Structure and dynamics of dicyandiamide: A theoretical study. Journal of Physical Organic Chemistry 4:125.
• Rannev N.V., Ozerov R.P., Datt I.D., Kshnyakina A.N. Kristallografya 1966, 11:175.
• Shibata M., Kagawa M., Morisaka K., Ishida T., Inohue M. Acta Crystallogr., Sect. C 1983, 39:1855.
• Kojic‐Prodic B., Ruzic‐Toros Z., Bresiani‐Pahor N., Randaccio L. (1980) 2-Cyano-1-methyl-3-{2-[(5-methyl-1H-imidazol-4-yl)methylthio]-ethyl}guanidine monohydrate. Acta Crystallographica Section B Structural Crystallography and Crystal Chemistry 36:1223.
• Manley P.W., Quast U. J. Med. Chem. 1992, 35:2327.
• Petersen H.J., Nielsen C.K., Arrigoni‐Martelli E. J. Med. Chem. 1978, 21:773.
• Dupont L., Dideberg O., Vermeire M. Acta Crystallogr., Sect. B 1979, 35:150.
• Allen F.H., Kennard O., Watson D.G., Brammer L., Orepen A.G., J. Chem. Soc., Perkin Trans. 2; 1987, S1.
• Sheldrick G.M. SHELXS 86, Program for the Resolution of Crystal Structures, University of Cambridge, U.K.; 1986.
• Sheldrick G.M. SHELX 76, Program for the Determination of Crystal Structures, University of Cambridge, U.K.; 1976.